Sunday, 29 November 2009
Some good news... some bad news...and some odd news
The good news is that NICE (which should be NIHCE by the way) is going to allow patients with rare diseases to receive important new drugs which have not been appraised by the NHS rationing body, Nice (National Institute for health and Clinical Excellence).
It will allow the makers to build up sufficient evidence on the benefits of the drugs which will then be used by Nice to decide if the medicine is cost effective enough for the NHS.
The bad news is that in order for the “makers to build up sufficient evidence on the benefits of the drugs” it will cost us £25 Million Andrew Dillon, Chief Executive of Nice, said: "We recognise that for a small number of very promising new treatments, the evidence available may not reveal their full potential benefits for patients.
"Where there is a high risk that a Nice appraisal of a new treatment at the point of its first use in the NHS might underestimate its benefits, providing the opportunity to gather more evidence and making the treatment available before undertaking an appraisal is the right thing to do.
“We’re happy to play our part in making this new arrangement work well, and that it works in the interests of patients and the NHS.”
The Innovation Pass pilot consultation will run for 10 weeks, closing on 8th February 2010. Input and comments are welcome from all groups including stakeholders, industry, the NHS and patient groups.
Here’s a comment: why are we paying money to the Pharmas to collect data on THEIR drugs when NICE is refusing cancer patients drugs on the basis of cost?
A bit of bad news:
The latest brown runny stuff to hit the whirly thing is of course the ‘revelation’ that the ratings given by the CQC may not be quite accurate.
Well surprise bloody surprise, Dr Foster that old medical man who went to Gloucester in the rain I believe has “discovered” that 27 trusts had unusually high death rates.
But the Care Quality Commission, which has issued its official ratings within the past month, said it saw no need to intervene to make improvements.
Its chairwoman said Dr Foster's report was part legitimate, part alarmist.
On Thursday, the Care Quality Commission (CQC) sent a task force into Basildon and Thurrock NHS Trust in Essex after it uncovered major lapses in hygiene and unusually high death rates.
Just 24 hours later, the chairman of Colchester Hospital University NHS Foundation Trust was sacked after inspectors found it had consistently failed to improve waiting times and had death rates 12% higher than expected.
Bloggers have been telling the ‘powers that be’ this for years, but as usual no one listened
If you want more info see Fridays post, but don’t bother to use the Dr Foster site because it keeps crashing.
And the Odd news:
A mother is being taken to court by her ex-partner for refusing to allow their daughter to have the swine flu vaccine.
The 44-year-old, a former international consultant, opted to take her daughter, 9, out of the immunisation programme run at her private school because she had reservations about the safety of the vaccine.
After spending hours researching it and speaking with friends in the medical profession, she decided that not enough was known about the long-term effects of the vaccine, and that her child, who has no medical problems, should not have it.
The mother said: "My former partner is adamant that he wants her to have the swine flu vaccine.
"I received an email from him saying he really wanted her to have the vaccine and I wrote back explaining my reasons and telling him it wasn't a decision I had taken lightly.
"The next thing I know, I received a letter telling me to attend court on Monday. His letter notified me of his application for a specific issue order, which I am told means our daughter could be made a ward of court and the judge could decide that she must have the injection.
"He knows I can't afford lawyers to fight him."
NHS figures show that under 16s are the age group most likely to be admitted to hospital with swine flu, while 21 per cent of deaths in England are among under-14s.
The Government says that trials of the swine flu vaccine have proved it to be as safe as the normal seasonal flu vaccine.
However, a poll of doctors for Pulse Magazine found that 49 per cent would refuse to have it, while a similar survey for GP magazine found 29 per cent would opt out, with 71 per cent stating safety fears as their reason why.
The Vaccine is being “tested” to identify any rare side effects of the swine flu vaccination by scientists in Dundee.
Although already tested as part of the licensing process, the new study will focus on any effects not picked up by routine clinical trials of the vaccine.
Discuss...
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Saturday, 28 November 2009
Darzi Clinics down the Kharzi
Why you may ask? and the reason is that Assura have lost £4.5 Million ‘running’ them.
“Despite having won or reached preferred bidder stage for 68 tenders, including a string of GP led health centres across the country, Assura revealed losses before interest and taxes in its medical division of £4.5m.
City experts say Assura shareholders would rather the GP operations were sold off or shut as they are not expected to earn enough money to make a profit for a considerable period.
Announcing its half yearly results, Assura warned that the current high volume of procurement for contracts, such as the Darzi rollout, was likely to slow after the general election and warned that the medical business would ‘be loss making for some time and will consume further cash.’
It added: ‘The board is in the process of evaluating a number of options to separate the GPCo business from the rest of the group.'
City analyst Investec said the move ‘could include sale, spin-off or closure’ of the GP ventures.
It added that it would cost Assura around £10m to spin off or close the ventures but that the benefits of either move would outweigh the long-term damage to the company’s share value of holding on to the loss making division.”
Despite opening a string of centres in Bath, Coventry, Stockton, Hartlepool, Reading, Hull, Hertford and Cheshunt, since April, just three of Assura’s GP companies reported a profit in the first six months of the year.
Well done Ara Darzi, you managed to waste millions on this half baked idea, and now that you are gone so are your clinics.
I think I may start a petition to re-nationalise the NHS.
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Friday, 27 November 2009
Is it time to bury Foundation Trusts?
“The way hospitals are regulated should be urgently reformed after a report found a catalogue of failings at two hospitals in Essex, a charity has said.”
The Patients Association said people had been "appallingly" let down.
The independent regulator highlighted an unusually high death rate and poor hygiene, including blood-spattered kit.
Basildon and Thurrock NHS trust said concerns were not indicative of wider problems, but a taskforce has been sent in to force through improvements.
The Patients Association said the failings were not isolated cases and patients had suffered a lack of monitoring, lack of help with feeding and a lack of dignity.
'Not complacent'
Director Katherine Murphy said: "How many times do the public need to keep hearing about this before the government is embarrassed enough to do something about it?
The Daily Fail reports it in a ‘slightly’ different way: “Dozens of patients died needlessly as a result of filthy conditions in an NHS hospital a shocking report said last night”
“Appalling nursing care in Basildon University Hospital contributed to a mortality rate that was more than a third higher than the national average. At least 70 people may have died who should have been saved.
It is the latest example of patients paying the ultimate price for labour’s failure to stamp out third world conditions in the NHS-despite trebling taxpayer funding over the last decade.”
Monitor the Foundation Trust regulator: We were established in January 2004 to authorise and regulate NHS foundation trusts. We are independent of central government and directly accountable to Parliament.
There are three main strands to our work:
And
Supporting NHS foundation trust development.
Assessing NHS trusts for NHS foundation trust status
We receive and consider applications from NHS trusts seeking foundation status and look at three areas:
Is the trust well governed with the leadership in place to drive future strategy and improve patient care?
Is the trust financially viable with a sound business plan?
Is the trust legally constituted, with a membership that is representative of its local community?
If we are satisfied that certain criteria are met, we authorise the trust to operate as an NHS foundation trust.
Regulating NHS foundation trusts
Once authorised, we regulate foundation trusts to ensure they comply with their terms of authorisation. These are a set of detailed requirements covering how foundation trusts must operate – in summary they include:
The general requirement to operate effectively, efficiently and economically;
Requirements to meet healthcare targets and national standards; and
The requirement to cooperate with other NHS organisations.
The board is the first line of regulation in NHS foundation trusts - we ask them to submit an annual plan and regular reports to us. We then monitor how well they are doing against these plans and identify where problems might arise.
Where problems start to develop we make sure the trust has an action plan in place and monitor progress against the plan. Where possible we work closely with a trust to resolve a problem quickly.
We have powers to intervene in a foundation trust in the event of failings in its healthcare standards, or other aspects of its leadership, which result in a significant breach of its terms of authorisation.
Take which view you like, this is not about funding, or the Government, although the “target driven policy” has not helped, the real problem is ‘Foundation Status’ which allows hospitals to become almost independent of the NHS.
NHS Foundation Trusts are a new type of NHS organisation, established as independent, not for profit public benefit corporations with accountability to their local communities rather than Central Government control.
The Secretary of State for Health has no powers of direction over them.
NHS Foundation Trusts remain firmly part of the NHS and exist to provide and develop healthcare services for NHS patients in a way that is consistent with NHS standards and principles - free care, based on need not ability to pay.
NHS Foundation Trusts have greater freedoms and flexibilities than NHS Trusts in the way they manage their affairs, this extends to:
Freedom from Whitehall control and performance management by Strategic Health Authorities
Freedom to access capital on the basis of affordability instead of the current system of centrally controlled allocations
Freedom to invest surpluses in developing new services for local people
Freedom of local flexibility to tailor new governance arrangements to the individual circumstances of their community
In line with the programme of reforms set out in The NHS Plan, NHS Foundation Trusts give more power and a greater voice to their local communities and front line staff over the delivery and development of local healthcare. NHS Foundation Trusts have members drawn from patients, the public and staff and are governed by a Board of Governors comprising people elected from and by the membership base.
The CEO, Medical Director and the Chairman have consistently refused to tell me why “M”s cancer was inoperable and what effect the sepsis had on her cancer.
Clinical focus-High
Patient focus-High
Staff focus-High
And yes I know you can say that one case does not make a failure, but the real failure is responsibility: responsibility of the people who work in foundation trusts devoid of any need to account to anyone.
The Healthcare Commission was about as much use as a paper scalpel and was totally biased toward the trusts, Monitor was only concerned with approving the maximum number of foundation trusts that it could in order to show patients how wonderful the NHS is and believed everything that the hospital management told them, and once approved the trusts were more or less left to get on with it.
The CQC is about the same as the Healthcare Commission in that it talks tough and does nothing until stories such as Mid Staffs and Basildon are splashed all over the media.
But the failures of those hospitals are due to poor care, by Consultants, Doctors, Nurses and the lack of leadership by management.
And I know that nurses will cry “not us” there are not enough Nurses on the wards and we work 14 hours a day and don’t even have time for a pee let alone looking after patients, and most do.
But in the two hospitals mentioned they didn’t; the Nurses failed, the Doctors failed and the Consultants failed, but hospital Doctors and particularly Consultants do not ‘rock the boat’, I am not going to get into “whistle blowing” because it is a moot point, but the deaths at Basildon happened because of the attitude of the staff, the lack of initiative, the lack of pride and worse of all the arrogance of the management.
The real problem as I see it is “Foundation Trust” hospitals; they should not be cut adrift from regulation, and along with the CQC and Monitor they do not work, they are not fit for purpose, all hospitals should be the same, regulated by one department with ad hoc powers to inspect without prior notice and with the power to close wards or even hospitals if need be, and to be able to sack senior managers all the way up to the CEO and Chairman if it is warranted.
Patient safety must be the number one priority in the NHS, it really is about time that hospitals were brought into line and provide the service that they are paid for and we deserve, and responsibility must be placed on those who fail to perform.
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Thursday, 26 November 2009
Value for Money-PCT Management
From Pulse, the whole thing:
PCTs have sanctioned staggering increases in management salary costs, with spending soaring by a quarter in just the past two years, a Pulse investigation reveals.
Many trusts project rises in management costs of 60% or more over the two-year period, with costs at one trust rising by more than 100%.
The steep increases coincide with a period in which investment in primary care has been curtailed and GP pay frozen.
Pulse obtained information from 55 PCTs under the Freedom of Information Act. At those trusts, projected spending on management salaries rose by 25%, from £312m in 2007/8 to nearly £390m in 2009/10.
The increase is partly through trusts taking on increasing numbers of managers, with 15 that provided head counts seeing their number of posts rise by 14% over two years.
But cost per management post also rose steeply, by 11% over two years. By contrast, latest figures show GP pay fell by 1.5% between 2006/7 and 2007/8, while investment in GP practices limped up by just 1.1% between 2007/8 and 2008/9.
NHS Hounslow topped the pile with an enormous 116% increase in manager salary costs over the two years, while at NHS Somerset costs rose by 72%.
Dr Barry Moyse, chair of Somerset LMC, said: ‘All our public services have seen an endless torrent of demands from the centre. Managers have no choice about whether to comply so the need for more managers grows inexorably.’
Mike Penning, Conservative shadow health minister, said: ‘These are shocking increases in the costs of bureaucracy and management within the NHS. It is inevitable the rises must be keeping money away from patient care and the front line.
‘Labour ministers must explain exactly why so much more is being spent on management after a reorganisation of PCTs that was intended to produce efficiency savings.’
The Department of Health said it was ‘for PCTs to determine their management costs’ and to ensure they were ‘securing value for money’.
But David Stout, director of the NHS Confederation’s PCT network, said: ‘A lot of this is spending trusts are carrying out in response to what the DH has asked for. If you ratchet up expectations on delivery you also ratchet up costs both in the unit cost of existing managers and the overall numbers.’
He admitted it was ‘unrealistic’ for such big increases to continue.
NHS North East Essex, which saw costs soar by 26% in the past year alone, blamed the rise on the cost of separating its provider and commissioning arms.
NHS Cornwall, which has seen a 15% increase in costs over two years, said some of the increase had been driven by national schemes such as piloting of Telehealth, requiring entirely new management teams.
Other PCTs were less forthcoming. NHS Surrey, which predicts it will spend around £7.8m on management costs this year, said it was unable to retrieve its earlier costs because they were with a previous supplier, while NHS Solihull claimed to have no projected figures at all.
GPC negotiator Dr Beth McCarron Nash said: ‘GPs are constantly being told by PCTs to make efficiency savings, but maybe it’s about time PCTs saved some of this by cutting back on some of these management positions.
‘This has been driven by wave after wave of Government initiatives and it’s not surprising so much NHS money has been wasted. What we need now is a period of calm.’
Excuses, excuses; we all know that all sectors in the NHS are management top heavy, we all know of hospitals that are “dependant” on contributions from charities and the public via ‘fun runs’ etc, to purchase equipment, while the CEOs are “earning” £150,000 plus, and the free “management car park” is full of Porsches, jags and Mercs, while the patients, many of whom are on a basic pension have to pay exorbitant parking charges.
The DOH of course takes no responsibility for these massive increases in management costs, saying “it was ‘for PCTs to determine their management costs’ and to ensure they were ‘securing value for money”
They wouldn’t know value for money if it crept up behind them and bit them in the arse.
One final point, who sanctioned the huge increases for the management? The management of course.
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Tuesday, 24 November 2009
Hospital Acquired Infections
Following the “emergency” surgery to repair a cut bowel and a leaking anastomosis, the MRSA caused the wound from the surgery to grow to 17cm by 5cm, while she lay in ICU, I suppose “M” was ‘lucky’ to survive only to die from undiagnosed bowel cancer.
HAIs are still a massive problem for patients:
There is This from the Taxpayers alliance.
And the Committee of Public Accounts has issued this, I don’t know the date.
1. Hospital acquired infections are those that are neither present nor incubating when a patient enters hospital. Their effects vary from discomfort for the patient, to prolonged or permanent disability and even death.[1] This is a very serious subject in terms of the impact on patients and costs to the National Health Service. The best estimates we have suggest that each year there are at least 100,000 cases of hospital acquired infection in England causing around 5,000 deaths, and the cost to the NHS may be as much as £1 billion a year.
2. Not all hospital acquired infection is preventable, since the very old, the very young, those undergoing invasive procedures and those with suppressed immune systems are particularly susceptible.[2] In his report the Comptroller and Auditor General estimated, from information provided by infection control teams in hospitals, that across all NHS Trusts infection rates could be reduced by 15 per cent by better application of existing knowledge and realistic infection control practices. Attributing costs to hospital acquired infection is complex and uncertain but the potentially avoidable cost is around £150 million a year.[3] On the basis of his report we took evidence from the NHS Executive and the Chief Medical Officer on what was known about the extent, cost and effects of hospital acquired infection and how infection control could be improved.
3. Two overall points emerge from our investigation:
The NHS do not have a grip on the extent of hospital acquired infection and the costs involved and are unlikely to have the information they need for a further 3 to 4 years. Without robust, up to date, data it is difficult to see how the Department of Health, the NHS Executive, health authorities and NHS Trusts can target activity and resources to best effect. This lack of data mirrors our concerns about significant weaknesses in NHS information and systems that have arisen in our recent hearings on medical equipment; inpatient admissions, bed management and patient discharge; and hip replacements. Effective information is essential for good management and effective health care, and central to NHS modernisation.
A root and branch shift towards prevention will be needed at all levels of the NHS if hospital acquired infection is to be kept under control. That will require commitment from everyone involved, and a philosophy that prevention is everybody's business, not just the specialists. Leadership and accountability, through the new controls assurance process, is crucial, as is education and training, and monitoring of performance and progress. New investment is also needed. The NHS Executive have launched an array of initiatives to help make this happen, but the results have yet to work through, and we are not convinced that the Executive have given these initiatives sufficient priority when allocating resources.
On improving infection control
(iii) The NHS Executive acknowledge that it should be possible to reduce the incidence of hospital acquired infection by 15 per or more, avoiding costs of some £150 million and saving lives. Since 1996, and particularly since 1998, the NHS Executive have taken a series of actions and initiatives to address this issue, but do not expect to see tangible, measurable progress until 2003. Such progress will be essential for the NHS to meet their duty and commitment to patients (paragraph 45).
(iv) Key to achieving progress will be the effective implementation of the new Controls Assurance System, which builds on the statutory duty of chief executives for quality of care. This will raise the profile of hospital acquired infection, especially in the 20 per cent of Acute NHS Trusts that do not have a strategy for dealing with it. Every Trust has to have a plan in place by July 2000 setting out priorities for action and produce an annual report on progress. We look to the NHS Executive to let us have an initial summary report of progress, priorities and key issues by the end of April 2003 (paragraph 46).
(v) Complacency, poor prescribing practice and misuse of antibiotics has led to the emergence of drug resistant infections. As the Chief Medical Officer told us, there are no simple solutions any more. The NHS Executive have now launched initiatives to look at the more prudent use of antibiotics, and to monitor and control prescribing including the new Government strategy to tackle antibiotic resistant infections announced in June 2000. We expect this work to lead to evidence-based guidance on effective prescribing strategies (paragraph 47).
(vi) Hospital hygiene is crucial in preventing hospital acquired infection, including basic practice such as hand washing. We find it inexcusable that compliance with guidance on hand washing is so poor. We note the steps the Executive have now taken to improve awareness and education, but look to them to audit progress and report back to us by the end of 2001 (paragraph 48).
(vii) The increased priority and attention that is rightly now being given to hospital acquired infection has not been matched by resources. Some new money, £5 million over two years, has been allocated, some extra infection control nurses have been appointed, and the Executive accept the case for investment in smaller wards and isolation facilities. The scale of hospital acquired infection calls for sufficient funding to ensure that hospitals can tackle the problem effectively, and so reduce the impact on patients and NHS costs (paragraph 49).
(viii) The NHS Executive recognises that more effective bed management can help reduce hospital acquired infection. Greater use of smaller rooms and single bed rooms is now part of health service planning, and the Executive accept that increased investment in isolation facilities is a priority. But high throughput of patients is also a factor. As we noted in our report on Inpatient Admissions, bed management and patient discharge, some hospitals are operating at very high levels of bed occupancy. Wider application of best practice will help Acute Trusts manage beds better. Trusts also need to ensure that infection control is an integral part of their bed management policies (paragraph 50).
(ix) The Chief Medical Officer accepts that in staffing infection control teams, a ratio of one nurse to 250 beds is a good benchmark for NHS Trusts. But many Trusts have much larger numbers of beds per nurse. While local variations in circumstances and practice may account for some of these variations, we expect the NHS Executive to carry out further research, in conjunction with the Infection Control Nurses Association, with the aim of developing staffing guidelines for Trusts (paragraph 51).
6. Various estimates of the size, cost and impact of the problem were presented to the Committee. Figure 1 summarises the key figures, their bases and their reliability. [5] Though not necessarily consistent with each other,[6] they suggested that:
At any one time around 9 per cent of patients had a hospital acquired infection;
There are at least 100,000 hospital acquired infections in England and Wales each year, and possibly many more;[7]
Around 5,000 patients die each year in the United Kingdom as a direct result of acquiring an infection;[8]
These infections may be costing the NHS around £1 billion a year;[9]
While few Trusts monitor infections that develop after a patient leaves hospital, several studies have indicated that between 50 and 70 per cent of surgical wound infections occur post-discharge.[10]
7. The NHS Executive acknowledged that hospital acquired infection was a very serious issue but that the information available was limited. The estimate that there were at least 100,000 cases of hospital acquired infection a year made a number of assumptions, excluded key areas such as teaching hospitals and intensive care units, and did not include infections that present post discharge. These could be significant and the 100,000 is likely to be an underestimate.[11] Research was continuing into post-discharge infection, and the Executive hoped to have the results in the summer, and promised to share it with us.[12]
8. The Executive did not have data on the incidence of hospital acquired infection by NHS region or Trust, nor comparative data between England, Northern Ireland, Scotland and Wales. In particular, they could not identify the worst performing hospitals.[13] They noted that hospital acquired infection was a world wide problem, but here too the information was sketchy. Any international information that was available was really just a composite of country-wide studies and it was very difficult to make judgements about international comparisons. But in the Executive's view, England was doing better generally than most Scandinavian countries, did roughly as well as the USA in relation to MRSA (methicillin resistant Staphylococcus aureus), but did not do as well as some other European countries such as France and the Netherlands. Overall, they saw England as in the middle of the league rather than at the top.[14]
Enough of the dry “facts” HAIs are fairly easy to combat, good hand hygiene by medical staff, visitors and the patients themselves is paramount,
As is “proper” cleaning and disinfecting of wards, beds, floors and equipment, I wonder how many cross infections are caused by the Oxygen level finger clips passed from patient to patient without being disinfected?
There are useful resources out there for both medical staff and the public, one such is haiwatchnews.com who also has a campaign called Not on my watch with tools and information regarding this serious topic, this is not an advert, just a source of information which is worth a visit.
Another decent source is the Safe Patient project again an American site.
Because sadly there are not many sources in the UK, at least not current sources, we seem to keep stats like this to “need to know”, and clearly the UK public are not on that list.
The office for national statistics has this for Clostridium Difficile and this for MRSA which seems to suggest that infections are falling, better late than never I suppose.
The point is that HAIs are serious, they disable and can kill, and the frustrating thing is that they are mostly preventable, with just a bit of thought and common sense thousands of patients could actually leave Hospital fitter than they were when they were admitted.
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Monday, 23 November 2009
TV Hospital Dramas-in perspective
Anthony Sumara the “ new “ Chief Executive of Mid Staffordshire foundation trust has decided in his wisdom that TV hospital dramas can be exciting and entertaining but they are often filled with unprofessional behaviour
He argues that such programmes are painting the NHS and its doctors and nurses in a poor light and not reflecting real hospital life.
And goes on to say “For example, what impression of a career in the NHS is set in the minds of young people aspiring to be the future generation of nurses, doctors or chief executives when they watch programmes filled with unprofessionalism and poor conduct?
Just in the past month or so, there have been numerous instances of this.
In Holby City and Casualty, nurses, doctors and other staff gossip, flirt and argue with each other, usually while treating a patient at the same time.
But, not to worry, the patient doesn't mind and more often than not joins in.
Patient confidentiality is breached constantly.
Cases are discussed regularly between staff, and even with other patients, in full earshot of anyone that can hear, including the patient themselves while nurses refer to patients affectionately as 'alkies' or 'the woman who never shuts up'.
Data breaches are common, with patient records left in public areas or worse, downloaded onto portable devices only to be lost later in the programme.
Eating, drinking and smoking directly outside A&E are also common practice while on duty and in areas where signs are clearly displayed to the contrary, as is the use of mobile phones to make personal calls.”
The above statement concerns me greatly: Mr Sumara has been brought into Mid Staffs to rectify the appalling record of patient deaths, but it seems he cannot tell fact from fiction, TV Hospital dramas are just that, dramas, they are stories written by script writers to entertain the public.
And contrary to his beliefs in the ‘real world’ patient confidentiality IS breached; Cases ARE discussed regularly between staff, in full earshot of anyone that can hear,
Data breaches ARE common, with patient records left in public areas or worse, downloaded onto portable devices only to be lost .
The use of mobile phones to make personal calls, eating, and drinking directly outside A&E ARE also common practices.
I know I have seen it happen, it may have been a few years ago but it still happens.
But back to the point, Mr Sumara is afraid that young people aspiring to be the future generation of nurses, doctors or chief executives will be corrupted by Holby City and Casualty, to be honest if “young people” are believing that the Medical “soaps” are true to life then I for one wouldn’t like to be treated by them, because they would lack the ability to distinguish between entertainment and the hard world of medicine.
But I think that the majority of those aspiring to become nurses or doctors have a good grasp of the difference between fact and fiction, unlike Mr Sumara.
I also think that Mr Sumara doesn’t have enough work to do, if he can spend his time watching Holby City and Casualty instead of reforming the abysmal mortality rates at Mid Staffs and assuring patients that the hospital is not a prelude to the cemetery.
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Friday, 20 November 2009
The doctor who died as a result of Labour's ISTCs
From the Telegraph:
By Andrew Gilligan.
The whole thing.
Dr Hubley’s is just the most serious in a growing list of cases which raise serious concerns about the safety of 'independent sector treatment centres', writes Andrew Gilligan.
Dr John Hubley's operation to remove a gall bladder was supposed to take an hour, and he was expecting to be home the same evening. Instead, in a "torrent" of blood, he was dead.
What killed him was not the operation, one of the simplest there is. Neither the pathologist at the inquest, nor one of the country's most eminent experts in the field, had ever heard of it being fatal. No, what killed Dr Hubley was a Government initiative.
If Dr Hubley had been treated at a proper hospital, heard the inquest, he would have lived. Instead, he was sent to one of New Labour's "independent sector treatment centres" – clinics run by private companies, but taking only NHS patients and wholly funded by the state.
To ministers, ever questing for the quick fix, ever faithful when it came to privatisation's magic healing powers, the ISTCs were a godsend. Ben Bradshaw, then a junior health minister, said they were "providing NHS patients with fast access to high-quality treatment and galvanising the NHS to raise its game". There are now around 40, cutting waiting lists around the country. But many ISTCs are also cutting corners.
Dr Hubley, for example, had a haemorrhage on the operating table – but the clinic, although it carried out dozens of operations a week, did not have enough swabs to stem the bleeding.
Incredibly, it didn't even hold any emergency blood stocks to replace the blood Dr Hubley had lost.
The surgeons wanted to ring the local NHS hospital and ask for blood, but there wasn't a phone in the operating theatre. Someone had to go outside and rummage around for his mobile. The blood took almost two hours to arrive in sufficient quantity. By that time, it was much too late.
Dr Hubley's is just the most serious in a growing list of cases which raise serious concerns about the safety of these clinics. So far, these have mostly been local stories. It's time to start joining them up.
On Wednesday, this newspaper reported that ISTCs operated by a company called Clinicenta across North London had been closed by the NHS "in the interests of patient safety" after "a number of incidents" understood to include up to two deaths.
This particular contract has only been going for six months, and has served just a handful of patients. Two deaths already, if that is the case, would seem poor odds. Clinicenta is part of Carillion, a construction company. What do builders know about surgery?
Earlier this year, a survey for the BBC in the West Country found that almost a third of leading trauma and orthopaedic surgeons believed their local ISTC did not operate safely. Four surgeons reported avoidable patient deaths. Twelve reported avoidable poor outcomes, with one saying: "The results are very poor and I have to redo the operations, with unhappy results."
Dr Mark Porter, of the BMA consultants' committee, tells me: "We have been extremely concerned about where ISTCs get their staff from. They sometimes use short-term staff from abroad, whose quality control is questionable compared to an NHS consultant." And the public is paying through the nose for it all. Earlier this year, Edinburgh University found that, under fixed-cost contracts, the ISTCs had been paid £1 billion for operations that never took place.
You may think private is better. If it's the London Clinic, it probably is. But these are new outfits, specifically set up to make money from the taxpayer. If someone tries to send you to one, just say no, because NHS patients are finding themselves transferred into a semi-private netherworld without the same checks and safeguards.
The coroner condemned the ISTC where Dr Hubley died as a "Mickey Mouse" operation. The clinic responded: "We met all the criteria and all the regulations. [Blood] was not a requirement."
Blood was not a requirement. Let that be the epitaph for this literally fatal wheeze.
No comment from me needed.
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Saturday, 14 November 2009
Too fat to retire
And goes on to say;- They believe an "epidemic of obesity" explains why the so-called baby-boomer generation are less able to carry out the basic tasks of life than those born before the Second World War.
The findings are significant because they suggest that unhealthy lifestyles are finally offsetting the advances of medical science in society.
They also raise serious concerns about the provision for elderly care as the results suggest people will live longer but less independent lives in the future.
They found that for the first time the "abilities" of those retiring after the year 2000 were lower than the "abilities" of those who had retired in the 1980s and 1990s.
The abilities included walking up and down stairs or to the shops, managing household chores, and basic tasks like dressing oneself, getting in and out of bed or eating.
Ever since the Second World War the health of pensioners has generally been on the up and life-expectancy has increased because of breakthroughs in medical science.
But since the 1960s, obesity levels, and unhealthy sedentary lifestyles, have also increased and at the beginning of this century they finally began to take their toll, claim the researchers.
In the 1960s only around 13 per cent of the population were considered obese compared with 32 per cent in 2000, they said.
With levels expected to reach 45 per cent in the next 20 years the problem is likely to get worse, the study added.
"If this is true, it's something we need to address," said Prof Seeman. "If this trend continues unchecked, it will put increasing pressure on our society to take care of these disabled individuals.
Scary huh?
But don’t worry, this research was done in America, more scare mongering to frighten us into the ‘perfect’ mold that the Gov wants us to conform to.
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Friday, 13 November 2009
Nurses, worth every penny
Nurses do not currently need degrees, but must take extra training to climb the NHS ladder.
Here is a quick breakdown of nursing posts, responsibilities and salaries.
Role: Nurse consultantNumber: 860Salary: £38k - £65kRole: Providing expert advice to patients and junior staff, and co-ordinating clinical research.Required qualifications: Diploma plus significant experience and specialist training.
Role: Modern matron/community matronNumber: 6,800Salary: £38k - £46kRole: Supervising ward managers, ensuring cleanliness standards are met and training junior staffRequired qualifications: Diploma plus specialist training, or experience equivalent to a master’s degree
Role: Nurse managerNumber: 7,600Salary: £30k - £40kRole: Managing wards and budgets, in addition to clinical work assessing and caring for patientsRequired qualifications: Diploma plus managerial training
Role: Nurse specialist/ team leaderNumber: Approx 40,000Salary: £25k - £34kRole: Taking lead in care for patients suffering from particular conditions, eg diabetes or Parkinson'sRequired qualifications: Diploma plus specialist clinical training
Role: MidwifeNumber: 25,000Salary: £25k - £34kRole: Supporting women during pregnancy and taking lead during labour and birthRequired qualifications: Degree in midwifery. Qualified nurses can become midwives by completing 18 month course.
Role: NurseNumber: 300,000Salary: £20k - £27kRole: Range of clinical roles from checking temperatures to administering blood transfusions.Required qualifications: Two or three year nursing diploma. Five good GCSEs usually required to win place at diploma course colleges.
Role: Healthcare assistant/auxiliary nurse/clinical support workerNumber: 180,000Salary: £13k - £18kRole: Washing, dressing and feeding and patients, making beds, and monitoring symptoms.Required qualifications: None, although assistants can take NVQs to become clinical support workers and qualify for nursing diploma course.
I have great respect for the majority of nurses, they do a wonderful job in very difficult circumstances.
I know this is over simplifying the situation and some nurses will go ballistic, but these are not my descriptions, so if there are any nurses out there who have the full story let me know.
And be gentle, I haven’t been well you know.
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Wednesday, 11 November 2009
Statins; be careful.
I wrote about his on another blog back in June this year, and it appears I may have been right:
The Medicines and Healthcare products Regulatory Agency is updating the product information on all statins to warn GPs and patients of a string of potentially dangerous side-effects.
The UK drug regulator has announced it will amend both the summaries of product characteristics and patient information leaflets to include warnings about side-effects caused by the drugs, including depression, sexual dysfunction and lung conditions.
In its November Drug Safety Update, the MHRA said a European-wide review on statins conducted in February 2008 found there was a need for fresh advice and information on the side-effects of statins.
‘The headline message from the review was that the balance of risks and benefits of statins remains positive,’ it stated.
‘However, the review also identified the need for the product information for all statins to reflect the issues identified from analyses of clinical trial and post-marketing data from adverse drug reactions. These included sleep disturbance, memory loss, sexual disturbances, depression, and interstitial pneumopathy.
‘On the basis of the data examined for individual statins and the class as a whole, the review concluded that there is sufficient evidence to support a possible causal relationship between statin use and the above adverse reactions.’
GPs are also warned to ‘be aware of the changes’ and discuss them with patients.
Dr Stewart Findlay, a GP in Bishop Auckland, County Durham, and a member of the Primary Care Cardiovascular Society board, said: ‘Sleep disturbances are quite common in primary care, but the others are not that common.'
'Generally, statins are well-tolerated drugs, but this might prompt us to keep an eye out. If a condition comes on soon after statins are started, it might be worth stopping them to see if it improves.’
I still take statins, and I still get the side effects; muscle pains, sleep disturbance, depression and breathlessness and I have had them since I started taking them, but when I mentioned these to my GP there was no real feedback, or advice.
So my advice-non medical of course is if you are offered statins because of your cholesterol levels, think very carefully before taking them, and if you suffer any of the serious side effects mentioned go back to your GP as soon as you can to discuss alternatives.
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Monday, 9 November 2009
Are Government targets killing patients?
Deadly superbugs have increased despite a crackdown on the best-known infections such as MRSA, a parliamentary report will warn this week.
While rates of MRSA and Clostridium difficile are falling, after scandals over major outbreaks, other potentially fatal infections which receive less attention appear to be soaring, the Commons public accounts committee will say.
Around 300,000 infections are diagnosed in English hospitals every year – but many more potentially fatal bugs may be going undetected, because of a lack of surveillance, research has found.
A voluntary scheme charting all bloodstream infections found numbers increased by 30 per cent between 2003 and 2007, in what the committee's chairman Edward Leigh described as a "rising tide" of infections threatening all hospital patients.
The report is expected to show increasing numbers of cases of E-coli, linked to surgical site infections and urinary tract problems, and in cases of the bacterial infection klebsiella.
The Sunday Telegraph has established that the NHS' most senior doctors and scientists responsible for infection control believe their efforts are being hindered by Government waiting targets.
An anonymous survey of 170 NHS directors of infection control found that 59 per cent had experienced a clash between their efforts to block the spread of disease and rules which say new patients must be found a bed within four hours.
Infection experts say NHS managers are so fearful of missing the four hour target for Accident and Emergency patients to be admitted to a ward, that infected patients are being shunted around overcrowded hospitals, hastening the spread of disease, in a rush to clear space for new arrivals.
The four hour target has already been implicated in a series of NHS hospital scandals, in which hundreds died, but, on each occasion, ministers have insisted that poor management, rather than the target, was to blame.
In total, 100 of 170 directors at England's hospital trusts reported difficulties as a result of the four hour target, in research carried out for the National Audit Office.
A Department of Health spokesman said MRSA bloodstream infections had fallen by 74 per cent since 2003/04 and C. difficile infections by 35 per cent between 2007/08 and 2008/009.
So why have more than 30,000 people died between 2004 to 2008 after contracting the hospital infections MRSA and Clostridium difficile?
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Saturday, 7 November 2009
GPs on the turn?
From Pulse:
A poll of 326 GPs reveals that in the wake of the major parties’ political conferences, the profession’s support for the Government is at its lowest level yet.
Just 8% said they would vote Labour in the next election, which is expected to be held early next summer. 52% said they would vote for the Conservatives and 22% for the Liberal Democrats.
7 respondents – equivalent to 2% of those polled – listed the British National Party as their preferred choice.
The poll will come as a blow to the Government, which has sought to portray Labour as the natural party of the health service. Health minister Mike O’Brien told Pulse last month: ‘Nothing better symbolises what Labour is about than the NHS.’
But even compared to recent surveys, the drop in support for the Government is striking. A poll of nearly 1,400 GPs in January found 15% would vote Labour, with 50% for the Conservatives and 19% for the Liberal Democrats.
Dr Paul Charlson, chair of the Conservative Medical Society, hailed the survey’s findings as a ‘resounding endorsement’.
‘The idea that GPs are to be trusted with real budgets to spend on commissioning care on behalf of their patients is particularly attractive to GPs who have become frustrated at the lack of progress in practice-based commissioning,’ he said.
‘Andrew Lansley and his team have taken the time and trouble to listen and understand what needs to happen at the grassroots to ensure that the NHS flourishes.’
Dr David Stokoe, a GP in Liverpool, said he was planning to vote Conservative, largely because of a lack of confidence in the Prime Minister.
‘I don’t have any evidence that they will be better for health than the others – but surely they can’t be worse,’ he said.
Dr Andrew Mimnagh, chair of Sefton LMC, said he was still an undecided voter.
‘I believe there are two certainties for GPs during the next parliament regardless of controlling party,’ he said. ‘They will be working longer and harder to the detriment of their personal life. And they will have less disposable income.’
Unlike the rest of us?
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Thursday, 5 November 2009
Hospital ratings and Choose and Book a waste of time and money?
Patients ignore hospital leagues tables and rely on their own experience or the advice of their family doctor when they choose where to be treated, a new survey suggests.
Despite extensive ratings available on everything from waiting times to the quality of the food, fewer than one in 20 consulted official figures.
Instead, they were much more likely to trust a recommendation from friends or family, the poll also reveals.
A drive by ministers to increase choice in the NHS has led to more and more detailed league tables being published.
These rate the performance of all the NHS trusts in England and award marks for a range of tests including cleanliness and the use of mixed-sex wards to the helpfulness of staff.
They are designed to help patients who can now decide where they would like to be treated using a computerised ‘Choose and Book’ system.
However, the information was ignored by the vast majority of patients, a study by the King’s Fund think tank found.
Just 4 per cent of patients, who were asked to tick as many sources of information as applied, said that they accessed the tables through the official NHS Choices website.
Another six per cent read a leaflet or a book about their choices, while nine per cent asked the adviser on a telephone line while making a booking.
By contrast, 41 per cent relied on their own past experience of the hospital and another 36 per cent asked their GP.
An additional 18 per cent relied on the experience of their friends or family when making the decision.
Another, more general survey by the fund, found that when asked where they heard about information about hospital 56 per cent agreed from personal experience, 52 per cent from friends and family, 50 per cent agreed from the media, and 13 per cent from their GP.
The study asked almost 6,000 patients who had been referred for hospital treatment.
Patients were most concerned about cleanliness and quality, while travel costs and parking were seen only as “somewhat important”.
A spokesman for the Department of Health said that NHS Choices now received seven million hits a month "and is one of the most popular health websites in the world".
So who is telling porkies then, the patients or the pointy heads at the Dept of Half-Arsed Ideas, now let me think.
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Wednesday, 4 November 2009
Gosport War Memorial Hospital-more news
Couple of items today, the first is from Portsmouth-the news which says “Lib Dem shadow health minister Norman Lamb MP has pledged support for relatives of patients who died at the Bury Road site during the 1990s. And he is backing their calls for a full-scale inquiry to be held.”
Grieving families want the hearing to get the issues surrounding their loved ones' deaths out into the open.They are also calling for a criminal prosecution to be brought against Dr Jane Barton, the clinical assistant in charge of the day-to-day running of Dryad and Daedalus wards where the patients died.They believe large doses of painkillers and sedatives prescribed by the GP led to some patients' deaths.Mr Lamb said: 'Failures by the police, Crown Prosecution Service, NHS and health regulators can be exposed and lessons learnt only if there is an open and transparent inquiry.'Charles Farthing, whose 79-year-old stepfather Arthur Cunningham, known as Brian, died on Dryad ward in September 1998, said: 'We need some heavyweight political backing to move this forward and we're hoping Mr Lamb can give us this.'We want a proper public inquiry and we want the government to release all the facts.'We are fighting for justice here and we hope political support will start opening up doors and finally get all the information on the table.
The rest of the article is available by clicking the link.
So why is it that a Lib Dem is the only MP interested in finding out the truth?
My thanks to VON who sent the link to me.
The other item is a comment posted on the Independent site on Sunday by valdan70
Inappropriate use of painkillers - GWMH
I was the Patient Affairs Officer at GWMH during part of the period post 1994 when this situation was ongoing. Part of my job was to return personal effects, help with funeral arrangements and pass death certificates to the families of the bereaved. I was concerned about the number of deaths occurring, particularly when on one afternoon alone (I worked 15 hours a week, from 2 p.m. until 5 p.m. Monday to Friday) the next of kin of 8 separate patients, who had passed away during the previous night, were waiting to see me. The cause of death on most of the death certificates was given as Pneumonia.I mentioned my concerns to several members of staff, and my manager, especially as I had been present on the wards when patients had been distressed and frightened about being prescribed painkillers administered via a driver. Some were frightened to go to sleep; they were afraid they would not wake up. I was always told I shouldn't involve myself in medical matters as it was none of my business. I have never been asked to give evidence at the inquests, or any of the enquiries. Eventually I resigned my post as I was unable to give the level of help necessary to the bereaved families in the 15 hours allocated to the post. In addition to counselling the bereaved, I arranged and attended funerals/cremations of those patients who had no family, and liaised with the Treasury Solicitor with regard to their affairs. I was also responsible for the patients' expenses and pensions, and the maintenance and auditing of the petty cash and other budgets on a weekly basis. The hospital's budgets were so tight; there was not enough money to fund the post in order to offer even a basic service.
This comment seems to have mysteriously disappeared from the site, so I cannot confirm it, I wonder why?
Other posts on GWMH can be read here.
Angus
Angus Dei on all and sundry
AnglishLit
Agnus Dei politico
Tuesday, 3 November 2009
Is it all in the mind? And finally!
Couple of subjects today, the first was sent to me by a friend, and the second is blindingly obvious.
Placebos Are Getting More Effective. Drug makers Are Desperate to Know Why.
Bits below:
In interviews with the press, Edward Scolnick, Merck's research director, laid out his battle plan to restore the firm to preeminence. Key to his strategy was expanding the company's reach into the antidepressant market, where Merck had lagged while competitors like Pfizer and GlaxoSmithKline created some of the best-selling drugs in the world. "To remain dominant in the future," he told Forbes, "we need to dominate the central nervous system."
His plan hinged on the success of an experimental antidepressant codenamed MK-869. Still in clinical trials, it looked like every pharma executive's dream: a new kind of medication that exploited brain chemistry in innovative ways to promote feelings of well-being. The drug tested brilliantly early on, with minimal side effects, and Merck touted its game-changing potential at a meeting of 300 securities analysts.
Behind the scenes, however, MK-869 was starting to unravel. True, many test subjects treated with the medication felt their hopelessness and anxiety lift. But so did nearly the same number who took a placebo, a look-alike pill made of milk sugar or another inert substance given to groups of volunteers in clinical trials to gauge how much more effective the real drug is by comparison. The fact that taking a faux drug can powerfully improve some people's health—the so-called placebo effect—has long been considered an embarrassment to the serious practice of pharmacology.
Ultimately, Merck's foray into the antidepressant market failed. In subsequent tests, MK-869 turned out to be no more effective than a placebo. In the jargon of the industry, the trials crossed the futility boundary.
MK-869 wasn't the only highly anticipated medical breakthrough to be undone in recent years by the placebo effect. From 2001 to 2006, the percentage of new products cut from development after Phase II clinical trials, when drugs are first tested against placebo, rose by 20 percent. The failure rate in more extensive Phase III trials increased by 11 percent, mainly due to surprisingly poor showings against placebo. Despite historic levels of industry investment in R&D, the US Food and Drug Administration approved only 19 first-of-their-kind remedies in 2007—the fewest since 1983—and just 24 in 2008. Half of all drugs that fail in late-stage trials drop out of the pipeline due to their inability to beat sugar pills.
The upshot is fewer new medicines available to ailing patients and more financial woes for the beleaguered pharmaceutical industry. Last November, a new type of gene therapy for Parkinson's disease, championed by the Michael J. Fox Foundation, was abruptly withdrawn from Phase II trials after unexpectedly tanking against placebo. A stem-cell startup called Osiris Therapeutics got a drubbing on Wall Street in March, when it suspended trials of its pill for Crohn's disease, an intestinal ailment, citing an "unusually high" response to placebo. Two days later, Eli Lilly broke off testing of a much-touted new drug for schizophrenia when volunteers showed double the expected level of placebo response.
It's not only trials of new drugs that are crossing the futility boundary. Some products that have been on the market for decades, like Prozac, are faltering in more recent follow-up tests. In many cases, these are the compounds that, in the late '90s, made Big Pharma more profitable than Big Oil. But if these same drugs were vetted now, the FDA might not approve some of them. Two comprehensive analyses of antidepressant trials have uncovered a dramatic increase in placebo response since the 1980s. One estimated that the so-called effect size (a measure of statistical significance) in placebo groups had nearly doubled over that time.
It's not that the old meds are getting weaker, drug developers say. It's as if the placebo effect is somehow getting stronger.
Interesting.
And:
One extra cleaner on hospital wards can reduce new cases of MRSA by a quarter while saving the NHS tens of thousands of pounds, Unison has claimed.
A research study sponsored by the union found that one extra cleaner on a hospital ward cut new cases of MRSA by one quarter and saved between £30,000 and £70,000.
The detailed study found that one extra cleaner targeting patient beds lockers, trays, buzzers and curtains with ordinary cleaning products. MRSA contamination on surfaces was reduced by one third.
The research was published in the journal BioMed Central Medicine and was carried out by microbiologist Dr Stephanie Dancer at the Southern General Hospital, Glasgow.
The cleaner worked on one ward for six months and then switched to another similar ward for six months. Cases of MRSA rose again after the cleaner changed wards.
Dave Prentis, General Secretary of Unison, said: “The number of cleaners employed by the NHS has been cut almost in two since the 80s and patients have paid the price.
"Armed with this evidence, Unison will be arguing that every cleaner plays an invaluable part in the control of infections and employing more in the NHS is a win, win situation – lives are saved as well as much needed NHS money.”
Dr Stephanie Dancer said: “It is very tempting to look for easy ways to clean a hospital ward. Look at all the wonderful ideas out there; bug buster dusters, clean air machines, kill-all disinfectants and gases, electrostatic wall tiles, copper lavatories, silver pyjamas and self-clean computers, for example.
"Whilst such things are innovative and interesting, we should not forget that basic hospital cleaning with detergent and water is the first line of defence against hospital infections.
"Cleaning is hard work, and complicated work, and the gadgets, gimmicks and gizmos cannot, and should not, replace a hospital cleaner."
Providing that you get the right cleaner of course.
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico
Sunday, 1 November 2009
Even the EU thinks our NHS is failing
Fire-hosing cash into the National Health Service has not produced the hoped-for results, judging by a recent consumer survey of European healthcare systems.
The NHS budget has more than doubled to £100 billion a year within 12 years, with at least three years of real-terms growth of seven per cent.
A major report in 2006 by the King's Fund into the unprecedented cash injection found some gains but established that only a quarter of the money actually improved services for patients. Most went on pensions and salaries for the service's 1.6 million staff.
Another indication that the money could have been better spent came last month from the Euro Health Consumer Index, which ranks national health care systems on 38 factors. These include treatment outcomes, waiting times, patients' rights and information.
Britain came 14th in 2009 and 13th in 2008. Despite the Government's drive to cut waiting times - because of their association with the huge problem of hospital-acquired infections – the NHS emerged badly on waits.
Perhaps more significant, however, is that the NHS has never performed as well as it did in the first consumer survey, in 2005 – before most of the refunding had come into effect. In 2005, the UK came in ninth. The following year it slid to 15th and slipped a further two places in 2007 to 17th.
However over the five-year spread of the index, health budgets across Europe have also increased, suggesting that the NHS has to continually up its game to keep place in the league.
In 2009, the NHS came one place below Ireland (13th) and one above Italy. The lowest rated countries were Bulgaria, Romania, Latvia and Albania.
The survey is carried out annually by Health Consumer Powerhouse, independent researchers based both in Brussels and Stockholm.
In 2009, the top countries from 33 in the table were 1 The Netherlands, 2 Denmark, 3 Iceland, 4 Austria, 5 Switzerland, 6 Germany, 7 France, 8 Sweden, 9 Luxembourg, and 10 Norway.
Now tell us something we don’t know.
Angus
Angus Dei on all and sundry
AnglishLit
Angus Dei politico